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Although the importance of the cellular microenvironment (soil)
during invasion and metastasis of cancer cells (seed) has been
well-recognized, technical challenges have limited the ability to
assess the inﬂuence of the microenvironment on cancer cells at the
molecular level. Here, we show that an experimental strategy,
competitive cross-species hybridization of microarray experiments,
can characterize the inﬂuence of different microenvironments on
cancer cells by independently extracting gene expression data of
cancer and host cells when human cancer cells were xenografted
into different organ sites of immunocompromised mice. Surpris-
ingly, the analysis of gene expression data showed that the brain
microenvironment induces complete reprogramming of metasta-
sized cancer cells, resulting in a gain of neuronal cell characteristics
and mimicking neurogenesis during development. We also show
that epigenetic changes coincide with transcriptional reprogram-
ming in cancer cells. These observations provide proof of principle
for competitive cross-species hybridization of microarray experi-
ments to characterize the effect of the microenvironment on tu-
mor cell behavior.
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During tumorgenesis, the changes in the local microenviron-ment play major roles in each step in metastasis from dis-
semination to colonization of distant organ sites (1–4).
Therefore, inhibition of the cross-talk between invasive cancer
cells and stromal cells might delay or completely block tumor
invasion and subsequent colonization of cancer cells. However,
a lack of understanding of the bidirectional communication be-
tween cancer cells and stromal cells at the molecular level
hampers the ability to develop and implement useful targeted
therapies.
Despite the potential to obtain stromal- and cancer-speciﬁc
signatures using laser-captured microdissection (5), segregating
cancer cells from stromal cells and vice versa remain a time-
consuming and labor-intensive procedure that is technically
challenging. There is also a high risk of failure because of in-
stability of RNA during cell isolation as well as the potential
systemic bias of gene expression during ampliﬁcation of partially
degraded RNA (6, 7). Thus, there is an urgent need for the
development of new experimental strategies that can delineate
cancer cell-speciﬁc gene expression signatures from stromal cell
signatures or vice versa.
In vivo xenografting of human cancer cells to different mouse
organs has the potential to elucidate the inﬂuence of the tumor
microenvironment on gene expression in cancer cells by mim-
icking the conditions that human metastases undergo at different
organ sites. Characterization of these in vivo models might
provide clues for the speciﬁc role of each unique tumor micro-
environment in determining the propensity of particular tumors
to metastasize to different sites as well as the sensitivity and
resistance to therapy at different sites. In the current study, we
have devised and performed proof of concept studies for an
experimental strategy, competitive cross-species hybridization of
microarray experiment (CHME), that can simultaneously ac-
quire gene expression patterns of cancer cells and host cells from
a single xenograft tissue by hybridizing an unmanipulated pop-
ulation of RNAs with human or mouse microarrays. This ap-
proach is based on the concept that, in xenograft tumor tissues,
all cancer cells are solely human, although all host cells are of
murine origin. When CHME strategy was applied to in vivo
metastasis models, it showed that CHME can reliably separate
complex gene expression patterns from mixed cell populations in
a single xenografted tumor mass and elucidate functional con-
sequences of tumor environment interactions.
Results
Competitive Cross-Species Hybridization. To selectively proﬁle tu-
mor and stromal cells in CHME, we used Illumina’s Sentrix
Beadchip microarrays, because they are based on long oligomer
DNA probes (50-mer) and use highly stringent hybridization
conditions (58 °C) during microarray experiments. To test spe-
cies speciﬁcity of DNA probes in Illumina’s human and mouse
microarrays, we ﬁrst conducted BLAST nucleotide searches of
mouse and human probe sequences on the Sentrix Beadchip
microarrays of the human and mouse mRNA databases, re-
spectively (8). The vast majority of human and mouse probes
showed low bit scores on cross-species BLAST nucleotide. In-
deed, more than 95% of human and mouse probes showed bit
scores less than 40 and 56, respectively (Fig. S1A), indicating
high species speciﬁcity of selected probe sequences.
To test the validity of the experimental strategy, we next carried
out cross-species hybridization of microarray experiments with
human (MDA-MB-231) and mouse RNA (immortalized astro-
cytes). Labeled cRNAs of human MDA-MB-231 and mouse
astrocytes were hybridized on both human and mouse microarrays
slides (Fig. S2A). To test the sensitivity of competitive hybridiza-
tion, ﬁve different mixtures (90% human and 10% mouse, 70%
human and 30% mouse, 50% human and 50% mouse, 30% hu-
man and 70% mouse, and 10% human and 90% mouse) were
applied to both human and mouse microarrays. Strikingly, signals
for more than 95% of the probes in human microarrays were
dependent on the amount of labeled human cRNA present in the
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hybridization (Fig. S1B), indicating that the presence of mouse
cRNAs (10%, 30%, 50%, 70%, or even 90%) did not compete or
signiﬁcantly inhibit hybridization between human cRNA and hu-
man oligo probes in the microarrays. Likewise, hybridization of
the mixtures on mouse microarrays showed similar patterns of
signal intensity (Fig. S1C), indicating that the presence of human
cDNA has minimal effect on hybridization of murine DNA to the
mouse microarray as well. These results strongly suggest that the
optimized experimental conditions with the Sentrix Beadchip
microarrays provide sufﬁcient speciﬁcity to discriminate expres-
sion of mouse and human genes when mRNA from both species is
mixed together and that they maintain the necessary sensitivity to
detect the expression of species-speciﬁc genes even when they only
represent 10% of the mRNA mixture.
Comparison of Gene Expression Proﬁles of Xenografted Tumors. To
test the feasibility of CHME to detect signals from human or
murine cells in in vivo conditions, we next carried out experi-
ments with xenografted human cancer cells (MDA-MB231Br3,
PC14Br4, KM12M, and A375SM) in mice. To examine the in-
ﬂuence of different microenvironments on the transcriptional
proﬁles of the cancer cells, cancer cells were xenografted in three
different murine organ sites (brain, skin, and orthotopic tumor
sites) as described in Fig. S2B. RNA from each xenografted
tissue was labeled, split into two parts, and hybridized to human
and mouse microarrays separately. Hierarchical clustering anal-
ysis was ﬁrst applied to gene expression data from a human
microarray representing cancer cells. As expected, the four dif-
ferent cancer cell lines xenografted orthotopically or s.c. were
clustered based on the identity of the cancer cell line in-
dependent of the location of the transplant with few exceptions
(Fig. 1A). For example, gene expression patterns of s.c.-xeno-
grafted breast cancer MDA-MB-231Br3 were very similar to
MDA-MB-231Br3 orthotopically xenografted to the mammary
fat pat, indicating that the gene expression program reﬂecting
the origin of cancer cells remains relatively unchanged even
when they were grown in two different peripheral micro-
environments (i.e., fat pad and skin in MDA-MB-231).
Surprisingly, with the exception of 2 PC14Br4 tumors and 1
KM12M tumor, 21 tumors from the four different cancer cell
lines growing in the brain showed substantially different gene
expression patterns to the same tumors at either the s.c. or
orthotopic site. The overall expression patterns lacked the cell
line-speciﬁc gene expression signature reﬂecting the cellular
origin of the cancer cells, indicating that cancer cells growing in
the brain no longer maintained their cell line-speciﬁc gene ex-
pression program. Because distinct gene expression patterns in
the cancer cells growing in the brain might be caused by the
contamination of human RNA with abundant mouse brain RNA,
we included mixtures of RNA from mouse brain and PC14Br4-
cultured cells in microarray experiments as control. Gene ex-
pression patterns of the mixed RNA were highly similar to
PC14Br4 xenografted to lung or skin (sample indicated by as-
terisk in Fig. 1A), strongly indicating that presence of mouse
brain RNA has a limited inﬂuence during hybridization on
human microarrays.
Species-speciﬁc detection of gene expression signals during
hybridization was also evident when hierarchical clustering
analysis was applied to gene expression data from mouse
microarray (noncancer cell data). The brain-xenografted tumors
clustered together with normal mouse brain samples and were
well-separated from the rest of tissues (Fig. 1B). Moreover,
mixed RNA (containing normal mouse brain RNA and PC14Br4
RNA) clustered with brain tissues, indicating that gene expres-
sion patterns from mouse microarrays were largely dependent on
mouse RNA in the xenografted tissues. To further validate
species-speciﬁc detection of gene expression and cancer cell-
speciﬁc expression of brain-induced genes in brain-xenografted
tumor, we carried out immunohistochemical (IHC) staining of
formalin-ﬁxed parafﬁn-embedded (FFPE) tissues from xeno-
grafted tumors. Our gene expression data showed that expres-
sion of CCL27, KIF1A, and NFIB is highly speciﬁc to MDA-MB-
231 cells xenografted to brain (Fig. S3A). IHC staining of FFPE
tissues with speciﬁc antibodies was in good agreement with gene
expression data. Although expression of three proteins was well-
detected in brain-xenografted human cancer cells, expression of
them in mouse brain (with xenografted human cancer cells in
neighbor) and human cancer cells xenografted in fat pad was
barely detectable (Fig. S3B). To further show that induced ex-
pression of CCL27 in brain-xenografted human cancer cells is
not caused by staining of mouse brain cells, FFPE tissues of
brain-xenografted MDA-MB-231 were double-stained with anti-
CCL27 and anti-GFAP, which is a speciﬁc marker for astrocytes
in brain, using immunoﬂuorescence techniques. Expression of
CCL27 is mutually exclusive to expression of GFAP in brain-
xenografted tumors (Fig. S3C), indicating that CCL27 is not
expressed in mouse brain cells. Thus, these data clearly showed
that expression of these proteins was only speciﬁc to human
cancer cells growing in the brain. In an additional subset analysis,
we selected genes with expression patterns that very signiﬁcantly
A B
Fig. 1. Gene expression patterns of xenografted tissues. (A) Hierarchical
clustering analysis of gene expression data from human microarray experi-
ments with xenografted tumors. Genes with expression variance within the
25th percentile and having at least a 1.5-fold difference in at least 20% of
samples relative to the median value across all samples were selected for
clustering analysis (11,156 gene features). The data are presented in matrix
format, in which rows represent individual genes and columns represent
each tissue. Each cell in the matrix represents the expression level of a gene
feature in an individual tissue. The color red or green in cells reﬂects relative
high or low expression levels, respectively, which is indicated in the scale bar
(log2-transformed scale). To test the inﬂuence of mouse RNA during hy-
bridization, mouse brain RNAs were mixed with the RNAs from PC14Br cells
in cell culture before microarray experiments (highlighted with asterisk). (B)
Hierarchical clustering analysis of gene expression data from mouse micro-
array experiments with the same xenografted tumor tissues used in human
microarray experiments. Expression data of 10,160 gene features were used
for this analysis after applying variance ﬁltration. Gene expression data
generated with mixed RNA were also highlighted. The ﬁrst and second
letters of the sample identiﬁcation code in the dendrogram represent cancer
cell lines and xenografted organ sites, respectively. A, A375SM; K, KM12M;
M, MDA-MB231Br3; P, PC14Br4 for cell lines. B, brain; C, cecum; F, fat pad;
L, lung; S, skin for organ sites.
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changed (P < 1.0 × 10−4) in brain-xenografted cancer cells
compared with fat pad-xenografted cancer cells and asked
whether their expression patterns are highly similar to those
patterns of mouse brain. Although a small fraction of gene ex-
pression patterns was similar to mouse brain, the majority of
them was very unique to brain-xenografted cancer cells (Fig.
S4A). This analysis also strongly suggested that altered gene
expression in brain-xenografted cancer cells is not caused by
cross-hybridization of mouse mRNA to human probes during
microarray experiments.
We next assessed differences in gene expression patterns
among the four cancer cell lines when growing in different organ
sites by applying ANOVA. Expression of a large number of
genes (4,213 genes) was signiﬁcantly different (P < 1.0 × 10−7)
among s.c.-xenografted tissues, reﬂecting inherent differences
in the transcriptomic program among the four cancer cell lines.
However, the same threshold cutoff (P < 1.0 × 10−7) only
identiﬁed 21 RNAs as signiﬁcantly different in the tumor lines
growing in the brain (Fig. S4 B and C), suggesting that the brain
microenvironment not only overrides the cell line-speciﬁc tran-
scriptome of cancer cells but also orchestrates a drastic reprog-
ramming of the cancer transcriptome to engender a similar gene
expression pattern in the different cell lines and cell lineages.
Acquisition of Neuronal Cell Characteristics of Cancer Cells in the
Brain Microenvironment. To uncover the characteristics underlying
the transcriptional pattern present in cancer cells in the brain
microenvironment, we applied gene set analysis from the tran-
scriptional proﬁles of A375SM cells growing in brain using In-
genuity Pathway Analysis. Surprisingly, the most enriched gene
sets among the up-regulated genes in A375SM growing in brain
were those sets involved in neurological signaling. For example,
genes implicated in neuropathic pain signaling, synaptic long-
term potentiation, axonal guidance signaling, and glutamate re-
ceptor signaling are signiﬁcantly enriched (Fig. S5 A–C).
SNAP25 (261-fold increase), SNAP91 (254-fold increase), and
BSN (181-fold increase) components of the neurotransmitter
complex that are uniquely expressed in neuronal cells were
highly up-regulated in tumor cells growing in brain (Fig. S5D)
(9–11), strongly suggesting that cancer cells in the brain micro-
environment acquire characteristics of neuronal lineage cells. In
support of the contention that cancer cells growing in the brain
microenvironment express genes typical of neurons, the expres-
sion of these genes in the three other cancer cell lines growing
in the brain showed marked overexpression of each of the can-
didates without any detectable expression when growing in
orthotopic or s.c. sites (Fig. S5E). In contrast, the most signiﬁ-
cantly enriched gene sets among down-regulated genes in tumor
cells growing in the brain related to energy-generating metabolic
pathways (Fig. S5F). Genes involved in oxidative phosphoryla-
tion (Fig. S5G), mitochondrial function, glycolysis/gluconeo-
genesis, and the pentose phosphate pathway were signiﬁcantly
down-regulated in cancer cells growing in brain.
Epigenetic Changes Driven by the Brain Microenvironment. The
characteristics of altered gene expression patterns in tumor cells
growing in the brain, the large number of differentially expressed
genes, and the acquisition of neuronal development lineage-
speciﬁc markers in all four cancer cell lines seemed to reﬂect the
differentiation or transdifferentiation of cells that occurs during
development rather than the progression of the cancer cells into
a more undifferentiated state. Because epigenetic events regu-
late the differentiation potential and fate speciﬁcation of stem or
progenitor cells (12), we next sought to investigate epigenetic
changes in the cancer cell lines growing in the brain.
We collected genome-wide methylation proﬁles of gene pro-
moters from the 24 xenografted tissues used for gene expression
proﬁling analysis. Unsupervised hierarchical clustering analysis
revealed that most of the tumors growing in the brain shared
a similar methylation proﬁle, whereas orthotopically xenografted
tissues showed characteristic methylation patterns reﬂecting the
origin of the cancer cell line, which was evidenced by distinctive
methylation patterns in each cell line (Fig. 2A). Interestingly,
three brain xenografts (two KM12M and one PC14Br4 xeno-
grafts) that grouped with orthotopically xenografted tissues in
gene expression proﬁling (Fig. 1A) also clustered together with
orthotopically xenografted tissues on methylation analysis.
Moreover, an orthotopically xenografted PC14Br4 sample pre-
viously grouped with tumor cells growing in brain based on
CHME clustered together with cells growing in brain based on
methylation proﬁling. These results strongly indicate that pro-
moter methylation proﬁle reﬂects and potentially contributes to
the gene expression proﬁle.
When direct association between methylation status of pro-
moters and expression of corresponding genes was estimated by
Pearson correlation coefﬁcient, marked concordance between
expression and methylation was observed. Of 490 hypomethy-
lated genes in cell lines growing in the brain, expression of 77.2%
of genes showed signiﬁcant correlation (P < 0.05). In particular,
the majority of genes (59.4%) showed an inverse correlation
(Fig. 2B), indicating that up-regulation of genes in cancer cell
lines growing in the brain might be caused, in part, by epigenetic
changes in gene promoters. In contrast, although a similar
number of promoters were hypermethylated in tumors growing
in the brain, these promoters were weakly associated with
changes in expression, with 33.4% of genes showing an inverse
correlation of expression with methylation (Fig. 2C).
The concordance of gene expression and methylation patterns
in tumor cells growing in the brain resembles cell fate de-
termination during development (13), and furthermore, tran-
scriptional programs of neuronal progenitor cells are changed
dramatically by transcription factors that respond to both in-
trinsic and extrinsic factors (14). Thus, we sought to ﬁnd po-
tential key transcriptional signaling networks that might drive the
dramatic reprogramming of the transcriptome of tumor cells
growing in the brain. Of 405 genes annotated as transcription
factors in the gene ontology database, we identiﬁed 65 genes as
brain-speciﬁc transcription factors with expression that is sig-
niﬁcantly higher (P < 0.001 by two-sample t test) (Fig. S6) in
brain tissues using the mouse gene expression data from the
normal brain. Among these genes, expression of 20 transcription
factors was signiﬁcantly (P < 0.001 by two-sample t test) up-
regulated in the human tumor cells xenografted in brain when
transcriptional proﬁles from human gene expression data were
analyzed independently (Fig. 3A).
Because epigenetic changes in regulatory regions of tran-
scription factors are key mechanisms for activation of fate-de-
termining genes (15, 16), we cross-compared expression of these
genes with methylation data. Among the brain-speciﬁc tran-
scription factors, the expression of six transcription factors
(PURB, ONECUT2, ESRRG, NFIB, TCF4, and MEF2C) was
signiﬁcantly (P < 0.001) associated with methylation of their
promoters. Speciﬁcally, expression of PURB, ONECUT2, ESRRG,
and TCF4 was negatively correlated with methylation, indicating
that they might be part of the core transcriptional signaling net-
work responsible for reprogramming the cancer transcriptome in
brain metastases (Fig. 3 B and C). Interestingly, ESRRG and
TCF4 have been implicated in differentiation of neuronal pro-
genitors and neuronal cell survival (17).
To validate epigenetic changes identiﬁed from methylation
microarray experiments, we carried out methylation-speciﬁc
PCR (MSP) experiments on CpG islands in promoter regions of
human ESRRG, CCL27, and SPI1 genes with genomic DNA
from xenografted tumors. Although most of the CpG islands
were highly methylated in fat pad-xenografted tumors, a signiﬁ-
cant proportion of the CpG islands was demethylated in brain-
17458 | www.pnas.org/cgi/doi/10.1073/pnas.1114210108 Park et al.
xenografted tumors, which was evidenced by differences in MSP
products (Fig. S7A). To ensure that the CpG islands examined in
microarrays and MSP reside in human promoters and not mouse
promoters, we carried out bisulﬁte sequencing of human pro-
moter regions of these genes. In consistent with previous anal-
yses, CpG islands in three genes were signiﬁcantly demethylated
in brain-xenografted tumors (Fig. S7B), strongly supporting that
demethylation in human CpG islands of promoter regions is
accountable for signiﬁcant negative correlation (CCL27, r =
−0.855; ESRRG, r= −0.833; SPI1, r= −0.903; P < 1.0 × 10−5 for
all three genes) between methylation status and expression of the
three genes observed from microarray experiments (Fig. S8).
Transcriptome Reprogramming Is Partially Induced by Coculture of
Cancer Cells with Astrocytes. Because extrinsic factors such as
cytokines and cell to cell interaction are key mediators for cell
fate determination during development (18), we hypothesize that
cellular stimulation that mimics the microenvironment of the
brain could induce the changes in transcriptomes observed in
cancer cells growing in the brain microenvironment. To test this
hypothesis, MDA-MB-231 cells were cocultured with mouse
astrocytes to mimic the microenvironment of brain or ﬁbroblast
NIH 3T3 cells as control. Gene expression data from each co-
culture were collected independently using cross-species hy-
bridization with human and mouse microarrays. Interestingly,
expression of a large number of genes (2,946 genes) was signif-
icantly (P < 0.001 by two-sample t test) altered when MDA-MB-
231 was cultured with astrocytes but not with ﬁbroblasts.
Moreover, the overall gene expression patterns of cancer cells
cocultured with astrocytes were remarkably similar to those
patterns from MDA-MB-231 growing in the brain, strongly in-
dicating that interactions with astrocytes might contribute to the
reprogramming of the cancer cell transcriptome (Fig. 4). Al-
though the patterns of changes were similar, the magnitude of
the effect was less with cultured astrocytes compared with the
cancer cells growing in the brain microenvironment, suggesting
that additional factors in the brain microenvironment participate
in full transcriptome reprogramming. To further test species
speciﬁcity of probes under our hybridization, we carried out
additional microarray experiments with GFP-expressing MDA-
MB-231Br3 cells that were FACS sorted after coculturing mouse
astrocytes or NIH 3T3 cells. Gene expression patterns of FACS-
sorted cancer cells that are almost free of mouse astrocytes were
highly similar to those patterns from directly harvested cancer
cells from coculture (Fig. S9). These data again strongly sug-
gested that our experimental condition for CHME was well-
optimized for detecting species-speciﬁc gene expression data
from mixed RNAs.
Discussion
The molecular and cellular characteristics of cancer cells meta-
static to particular organs remain unclear because of, in part, the
lack of experimental approaches that can characterize metastatic
tumor cells and the microenvironment at the molecular level. In
this study, we showed that an experimental strategy, CHME, can
characterize the transcriptome of cancer cells in metastatic sites
by discriminating gene expression signatures of cancer cells from
host cells in a single xenograft tissue. This approach allowed us
to uncover unexpected characteristics of cancer cells in a brain
metastasis mouse model, showing that the tumor cells acquire
expression patterns found in neuronal cells.
Several lines of evidence indicate that the microarray platform
and experimental conditions applied achieved sufﬁcient sensi-
tivity and speciﬁcity to distinguish signals of tumor cells from
stroma cells and vice versa. First, microarray experiments with
mixtures of human and mouse RNA showed that hybridization
conditions can discriminate foreign species of RNA even when
they constitute 90% of the RNA mixture and can detect ex-
pression of species-speciﬁc genes even when they only represent
10% of the mRNA mixture (Fig. S1). Second, the global gene
expression pattern of the RNA mixtures (mouse brain and
PC14Br4 cell line from tissue culture) was highly similar to
A B
C
Fig. 2. Epigenetic changes driven by brain microenvironment. (A) Unsupervised clustering of methylation proﬁles in xenografted tumors. The methylation
data showing the top 25% of variance were used for this analysis. The clustering analysis was performed after median centering of methylation data across
tissues in each cancer cell types. In the tissue identiﬁcation code row of the dendrogram, three brain-xenografted tissues (two KM12M and one PC14Br4 tissues)
grouped with orthotopically xenografted tissues in gene expression clusters are highlighted in red, and an orthotopically xenografted PC14Br4 sample grouped
with brain-xenografted tissues in gene expression clusters is highlighted in blue. (B) Pearson correlation coefﬁcient calculation of the genes showing hypo-
methylation in brain-xenografted tumors. (C) Pearson correlation coefﬁcient calculation of the genes showing hypermethylation in brain-xenografted tumors.
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PC14Br4 xenografted to lung or skin when they were hybridized
with human microarrays but was highly similar to brain tissue
when they were hybridized to mouse microarrays (Fig. 1). Third,
IHC staining of FFPE tissues clearly showed that human cancer
cells in brain-xenografted tissues exclusively express brain xe-
nograft-speciﬁc genes (Fig. S3). Fourth, gene expression patterns
of FACS-sorted (free of mouse astrocytes) cancer cells from
cocultures are highly similar to those patterns of cancer cells
directly harvested from coculture (Fig. S9). Our data show that
cancer cell-speciﬁc gene expression patterns can be clearly elu-
cidated in a tumor mass consisting of a mixture of cancer cells
and nontumor host cells without extensive cell manipulation
or microdissection.
Transcriptome reprogramming of the cancer cells growing in
tumors resembles the fate determination of neuronal stem cells
mediated by dynamic interplay of extrinsic factors, such as en-
vironmental signals and cell to cell interactions, and intrinsic
factors, such as epigenetic and transcriptional events (15, 16).
Coculture of cancer cells (MDA-MB-231) with mouse astrocytes,
mimicking the microenvironment in brain, induced transcriptome
reprogramming, indicating that interactions with astrocytes might
contribute extrinsic factors triggering intrinsic transcriptional
events. Our previous study showed that physical interaction be-
tween astrocytes and cancer cells is necessary for induction of gene
expression (19). Although selective genetic events in the brain
microenvironment might contribute to reprogramming of the tu-
mor transcriptome, the high concordance between promoter
methylation proﬁle and gene expression proﬁles strongly suggests
that epigenetic events contribute to transcriptome reprogram-
ming. Four transcription factors (PURB, ONECUT2, ESRRG, and
TCF4) were markedly induced in tumor cells growing in the brain
and showed a signiﬁcant negative correlation between methylation
status and gene expression status. TCF4 has previously been im-
plicated in neuronal cell differentiation and maintenance, sug-
gesting that it may be a contributor (14).
In breast cancer, clinically symptomatic metastases to the
brain occurs in 10–15% of patients who develop metastatic
breast cancer (20). Unfortunately, brain metastases shows a poor
response to chemotherapeutic agents that are active in the pri-
mary tumor site (21). The unexpected characteristics of tumor
cells growing in the brain elucidated by our experimental ap-
proach may help to explain the mechanisms underlying the
chemoresistance of these tumors. Malignant glioblastoma, the
most aggressive type of brain tumor, is highly resistant to che-
motherapy (22, 23). In addition to the existence of a blood–brain
barrier, which potentially limits the delivery of therapeutic agents
to the metastatic tumor, the lack of response to chemotherapy
could be because of, in part, the intrinsic resistance of cancer
cells that is an inherent characteristic of neuronal lineage cells.
When xenografted in the brain, all four cell lines tested in this
study acquired neuronal expression patterns that can also be
induced by culture with astrocytes (Fig. 4). Taken together, our
data suggest that acquisition of neuronal transcriptional patterns
in cancer cells might contribute to the chemoresistance nature of
brain metastasis tumors. Although the strong correlation be-
tween epigenetic changes with transcriptome reprogramming is
compatible with methylation playing a role in the transcriptional
changes, the key events that trigger the transcriptome reprog-
ramming remain to be fully elucidated.
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Fig. 3. Brain-speciﬁc transcription factor. (A) Heat map of brain-speciﬁc
transcription factors in human gene expression proﬁles; 20 transcription
factors that were shown brain-speciﬁc expression in mouse array data (Fig.
S6) and signiﬁcant increases in brain-xenografted tumors in human array
data (P < 0.001) at the same time were selected for the presentation of their
expression. (B) The transcription factors showing signiﬁcant correlation be-
tween methylation and expression in MDA-MB-231Br3 cells were xeno-
grafted in brain and fat pad; 11 transcription factors showing signiﬁcant
increase in its expression in brain-xenografted tumors (P < 0.001 and more
than threefold) with signiﬁcant correlation with methylation status (P <
0.001) were presented. (C) Scatter plot of four brain-speciﬁc transcription
factors that are showing signiﬁcant negative correlation between gene ex-
pression and methylation status.
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Fig. 4. Comparison of in vitro coculture signature with in vivo brain-xeno-
grafted signature. Expression pattern of 1,085 genes with expression that is
signiﬁcantly (P < 0.001 by two-sample t test) altered by both coculture with
mouse astrocytes and brain microenvironment. Before clustering, gene ex-
pression data were median centered independently.
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Materials and Methods
For application of CHME strategy to in vivo metastasis models, human cancer
cells were introduced into various organ sites, including brain, skin, fat pad,
cecum, and lung, in immunocompromised mice to mimic the in vivo micro-
environment of different sites of metastasis. Gene expression data from
human and mouse microarrays were independently collected from harvested
tumor masses. Detailed methods for all experiments and statistical analyses
are provided in SI Materials and Methods.
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